Reversible Pulmonary Hypertension in an Infant Treated with Diazoxide [PDF]
Background: Diazoxide is the main therapeutic agent for congenital hyperinsulinism. The drug is generally well tolerated; however, in this report severe adverse effects including heart failure (HF) and pulmonary hypertension (PH) in an infant are ...
Masoud Dehdashtian
doaj
Control of Kir channel gating by cytoplasmic domain interface interactions [PDF]
Alekseev +77 more
core +2 more sources
Синдромна характеристика спадкової ендокринної патології. [PDF]
Резюме. В огляді наведено коротку клінічну характеристику деяких синдромів ендокринної патології, основу яких складають спадкові чинники. Для позначення нозологічних форм зазначено ОМІМ згідно з існуючою класифікацією, тип успадкування, групи генів, що ...
В.П. Пішак, М.О. Ризничук
core
Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers [PDF]
Alena Welters +6 more
core +1 more source
Acute metabolic acidosis in a GLUT2-deficient patient with Fanconi-Bickel syndrome: new pathophysiology insights [PDF]
Fanconi-Bickel syndrome is a rare autosomal-recessive disorder caused by mutations in the SLC2A2 gene coding for the glucose transporter protein 2 (GLUT2).
Bensman, Albert +9 more
core
Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage [PDF]
core +1 more source
Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
Background Congenital hyperinsulinism is a rare disorder characterized by inappropriate insulin secretion, leading to persistent hypoglycemia. One genetic subtype, hyperinsulinism–hyperammonemia syndrome, results from activating mutations in the GLUD1 ...
Miral M. Abdulghfar +3 more
doaj +1 more source
Congenital central hypoventilation syndrome with hyperinsulinemia in an infant [PDF]
Andrew Wilson +5 more
core +1 more source

